162 related articles for article (PubMed ID: 33371107)
1. Therapeutic efficacy and immunoregulatory effect of Qiangji Jianli Capsule for patients with myasthenia gravis: Study protocol for a series of randomized, controlled N-of-1 trials.
Weng S; Fan Z; Qiu G; Liu F; Huang L; Li J; Jiang X; Song Z; Gao Y; Zhong Z; He L; Kang L; Wu Y; Chen B; Jiang Q
Medicine (Baltimore); 2020 Dec; 99(51):e23679. PubMed ID: 33371107
[TBL] [Abstract][Full Text] [Related]
2. Ephedrine as add-on therapy for patients with myasthenia gravis: protocol for a series of randomised, placebo-controlled n-of-1 trials.
Vrinten C; Lipka AF; van Zwet EW; Schimmel KJ; Cornel MC; Kuijpers MR; Hekster YA; Weinreich SS; Verschuuren JJ
BMJ Open; 2015 Jul; 5(7):e007863. PubMed ID: 26185179
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of modified Buzhong Yiqi decoction in treating myasthenia gravis: study protocol for a series of N-of-1 trials.
Weng S; Li J; Chen B; He L; Zhong Z; Huang L; Zhang S; Liu F; Jiang Q
Trials; 2022 Apr; 23(1):365. PubMed ID: 35477531
[TBL] [Abstract][Full Text] [Related]
4. Treatment of myasthenia gravis with the method of tonifying spleen and replenishing qi in traditional Chinese medicine: A protocol for systematic review and meta-analysis.
Jiang L; Xu P; Zhang D; Lu J; Chang T; Zhang Y; Wang J
Medicine (Baltimore); 2022 Jan; 101(3):e28530. PubMed ID: 35060508
[TBL] [Abstract][Full Text] [Related]
5. Tonifying spleen and replenishing kidney method of traditional Chinese medicine for myasthenia gravis: A protocol for systematic review and meta-analysis.
Lu B; Ye Q; Pan Y; Lu J; Li L; Peng Y; He M; Chen W; Yang X
Medicine (Baltimore); 2021 May; 100(21):e25966. PubMed ID: 34032708
[TBL] [Abstract][Full Text] [Related]
6. Traditional Chinese medicine in the treatment of idiopathic pulmonary fibrosis based on syndrome differentiation: Study protocol of an exploratory trial.
Yu XQ; Yang SG; Xie Y; Li JS
J Integr Med; 2020 Mar; 18(2):163-168. PubMed ID: 31928920
[TBL] [Abstract][Full Text] [Related]
7. Acetylcholinesterase inhibitor treatment for myasthenia gravis.
Mehndiratta MM; Pandey S; Kuntzer T
Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD006986. PubMed ID: 25310725
[TBL] [Abstract][Full Text] [Related]
8. The efficacy and safety of Jian-Wei-Qu-Tong Pills for the treatment of chronic non-atrophic gastritis (spleen and stomach qi deficiency with damp-heat stasis syndrome): study protocol for a phase II, randomized controlled trial.
Zhang XX; Chen WW; She B; Luo RJ; Shi N; Xue P; Yang XN; Xia Q
Trials; 2014 Jul; 15():272. PubMed ID: 25002101
[TBL] [Abstract][Full Text] [Related]
9. Yifei Sanjie Formula or Placebo With Anlotinib as Second-Line or Above Treatment for Metastatic Non-Small-Cell Lung Cancer: Study Protocol for a Double-Blind, Placebo-Controlled Randomized Pilot Study.
Chen W; Lin J; Yang T; Xin Zhang Z; Tao L; Xiao Z; Chen H; Qi X; Sun L; Cao Y; Lin L
Integr Cancer Ther; 2023; 22():15347354221151147. PubMed ID: 36710490
[TBL] [Abstract][Full Text] [Related]
10. Modified Buzhong Yiqi decoction for myasthenia gravis: A systematic review protocol.
Jiang X; Chen G; Huang J; Xie L; Shen D; Jiang K; Xu H
Medicine (Baltimore); 2018 Dec; 97(50):e13677. PubMed ID: 30558075
[TBL] [Abstract][Full Text] [Related]
11. Invigorating spleen, replenishing qi and tonifying kidney method treatment of traditional Chinese medicine for myasthenia gravis: A protocol for systematic review and meta-analysis.
Liu M; Wang H; Lv Z; Lu J; Zhang D; Zhu Z; Wu C; Tian Y; Song C; Wu T; Liu L; Chen X
Medicine (Baltimore); 2022 Dec; 101(50):e32285. PubMed ID: 36550924
[TBL] [Abstract][Full Text] [Related]
12. Clinical remission of moderate generalized myasthenia gravis through exclusive use of Buzhong Yiqi decoction: A case report.
Qiu H; Chen X; Zhang L; Zhang Q; Qiu C; Li J
Explore (NY); 2024; 20(4):588-591. PubMed ID: 38744568
[TBL] [Abstract][Full Text] [Related]
13. A Randomized Open-Labeled Trial of Methotrexate as a Steroid-Sparing Agent for Patients With Generalized Myasthenia Gravis.
Di L; Shen F; Wen X; Lu Y; Zhu W; Wang M; Da Y
Front Immunol; 2022; 13():839075. PubMed ID: 35371086
[TBL] [Abstract][Full Text] [Related]
14. The efficacy and safety of Jiedu Tongluo granules for treating post-stroke depression with qi deficiency and blood stasis syndrome: study protocol for a randomized controlled trial.
Zhao AM; Qiu WR; Mao LJ; Ren JG; Xu L; Yao MJ; Bilinksi K; Chang D; Liu JX
Trials; 2018 May; 19(1):275. PubMed ID: 29747670
[TBL] [Abstract][Full Text] [Related]
15. Effect of treatment with Fufang Huangqi decoction on dose reductions and discontinuation of pyridostigmine bromide tablets, prednisone, and tacrolimus in patients with type I or II myasthenia gravis.
Caifeng S; Jingsheng Z; Yi L; Xueshi H; Zhanyou W; Haiou P; Wenjun Q
J Tradit Chin Med; 2022 Oct; 42(5):810-817. PubMed ID: 36083490
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of naotaifang capsules for hypertensive cerebral small vessel disease: Study protocol for a multicenter, randomized, double-blind, placebo-controlled clinical trial.
Fang R; Hu H; Zhou Y; Wang S; Mei Z; She R; Peng X; Jiang Q; Wang X; Xie L; Lin H; Meng P; Zhang K; Wang W; Xie Y; Liu L; Tong J; Wu D; Luo Y; Liu C; Lu Y; Yu S; Cheng S; Xu L; Fang Z; Shang H; Ge J
Front Pharmacol; 2022; 13():967457. PubMed ID: 36686705
[No Abstract] [Full Text] [Related]
17. Efficacy and safety of Hou Gu Mi Xi in patients with spleen qi deficiency syndrome who underwent radical gastrectomy for gastric cancer: protocol for a multicenter, randomized, double-blind, placebo-controlled trial.
Zhou X; Yan DM; Zhu WF; Liu WJ; Nie HY; Xu S; Jiang YP; Zhang KH; Fu Y; Wan YY; Yu XY; Li H; Sun X; Chen XF
Trials; 2019 Jun; 20(1):343. PubMed ID: 31182140
[TBL] [Abstract][Full Text] [Related]
18. Treatment of hospital-acquired pneumonia with multi-drug resistant organism by Buzhong Yiqi decoction based on Fuzheng Quxie classical prescription: study protocol for a randomized controlled trial.
Deng D; Chen Z; Jia L; Bu J; Ye M; Sun L; Gen Y; Zhang W; Chen G; Fang B
Trials; 2019 Dec; 20(1):817. PubMed ID: 31888702
[TBL] [Abstract][Full Text] [Related]
19. Efficiency and Safety of Baofei Granules in Chronic Obstructive Pulmonary Disease (Lung and Spleen Qi Deficiency Syndrome): A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase II Clinical Trial.
Sun Y; Chen X; Zhang L; Yuan WA; Chen Q; Zhang YB; Liu LJ; Zhang W; Sun M
Drug Des Devel Ther; 2022; 16():4251-4267. PubMed ID: 36540716
[TBL] [Abstract][Full Text] [Related]
20. [Effects of Xiaopi Yishen herbal extract granules in treatment of fatigue-predominant subhealth due to liver-qi stagnation and spleen-qi deficiency: a prospective, randomized, placebo-controlled and double-blind clinical trial].
Wang TF; Xue XL; Zhang YJ; Han P; Li Z; Wang WP; Xing JM; Wang QB; Tang Y; Li L; Wang JJ; Li GR; Ji SL; Wu LX; Zhao Y; Wu XY; Zhao RS
Zhong Xi Yi Jie He Xue Bao; 2011 May; 9(5):515-24. PubMed ID: 21565137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
